As the U.S. stock market navigates through a period of volatility driven by tariff uncertainties, investors are keenly observing how these developments impact major indices like the Dow Jones and S&P 500. In such an environment, growth companies with substantial insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business's operations and future prospects.
Name | Insider Ownership | Earnings Growth |
Super Micro Computer (NasdaqGS:SMCI) | 14.2% | 29.8% |
Duolingo (NasdaqGS:DUOL) | 14.4% | 37.3% |
Hims & Hers Health (NYSE:HIMS) | 13.2% | 21.8% |
Credo Technology Group Holding (NasdaqGS:CRDO) | 12.3% | 64.8% |
Astera Labs (NasdaqGS:ALAB) | 15.9% | 61.4% |
Clene (NasdaqCM:CLNN) | 19.5% | 63.1% |
Niu Technologies (NasdaqGM:NIU) | 36.2% | 82.8% |
BBB Foods (NYSE:TBBB) | 16.2% | 34.6% |
Upstart Holdings (NasdaqGS:UPST) | 12.7% | 100.1% |
Credit Acceptance (NasdaqGS:CACC) | 14.4% | 33.5% |
Click here to see the full list of 198 stocks from our Fast Growing US Companies With High Insider Ownership screener.
Here's a peek at a few of the choices from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Astrana Health, Inc. is a healthcare management company offering medical care services in the United States with a market cap of approximately $1.51 billion.
Operations: The company's revenue is primarily derived from three segments: Care Delivery ($136.67 million), Care Partners ($1.95 billion), and Care Enablement ($155.45 million).
Insider Ownership: 12.8%
Revenue Growth Forecast: 14.3% p.a.
Astrana Health demonstrates strong growth potential with forecasted earnings growth of 26.5% annually, outpacing the US market. Despite a significant revenue increase to US$665.21 million in Q4 2024, net loss was reported at US$6.95 million due to lower profit margins compared to the previous year. The company has secured substantial financing through an amended credit agreement, supporting future acquisitions and investments while managing existing debt obligations efficiently.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Daqo New Energy Corp. manufactures and sells polysilicon to photovoltaic product manufacturers in China, with a market cap of approximately $1.02 billion.
Operations: The company's revenue segment primarily comprises the sale of polysilicon, generating approximately $1.03 billion.
Insider Ownership: 22.2%
Revenue Growth Forecast: 21% p.a.
Daqo New Energy is forecast to achieve significant growth, with earnings expected to increase 83.38% annually and revenue projected to grow at 21% per year, surpassing the US market average. Despite a recent net loss of US$345.22 million for 2024, the company trades at a substantial discount to its estimated fair value and aims for profitability within three years. Production guidance indicates potential operational stability with planned polysilicon output between 110,000MT and 140,000MT for 2025.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: JinkoSolar Holding Co., Ltd. and its subsidiaries are involved in the design, development, production, and marketing of photovoltaic products with a market capitalization of approximately $835.59 million.
Operations: JinkoSolar's revenue is primarily derived from its manufacturing segment, which generated CN¥92.26 billion.
Insider Ownership: 37.4%
Revenue Growth Forecast: 10% p.a.
JinkoSolar Holding is expected to see its earnings grow significantly at 61% annually, outpacing the US market's average. However, recent financial results show a challenging year with a net loss of CNY 473.73 million in Q4 2024 and declining profit margins. The company trades well below its estimated fair value despite these setbacks. Legal challenges include a patent infringement lawsuit from First Solar, potentially impacting future operations and growth prospects.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include NasdaqCM:ASTH NYSE:DQ and NYSE:JKS.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.